REPEATED ADJUVANT CHEMOTHERAPY WITH PHENYLALANINE MUSTARD OR 5-FLUOROURACIL, CYCLOPHOSPHAMIDE, AND PREDNISONE WITH OR WITHOUT RADIATION, AFTER MASTECTOMY FOR BREAST CANCER
- 1 April 1978
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 311 (8070), 893-896
- https://doi.org/10.1016/s0140-6736(78)90678-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug toleranceCancer, 1977
- L-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)Cancer, 1977
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- An analysis of a multiple‐drug program in the treatment of patients with advanced breast cancer utilizing 5‐fluorouracil, cyclophosphamide, and prednisone with or without vincristineCancer, 1975
- L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast CancerNew England Journal of Medicine, 1975
- Modern Management of Breast CancerArchives of Surgery, 1972
- Surgical Treatment of Breast CancerArchives of Surgery, 1970
- The significance of axillary node levels in the study of breast carcinomaCancer, 1955